TY  - JOUR
A1  - Petersen, Jens A.
A1  - Kuntzer, Thierry
A1  - Fischer, Dirk
A1  - von der Hagen, Maja
A1  - Veronika, Angela
A1  - Lobrinus, Johannes A.
A1  - Kress, Wolfram
A1  - Rushing, Elisabeth J.
A1  - Sinnreich, Michael
A1  - Jung, Hans H.
T1  - Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects
JF  - BMC Neurology
N2  - Background: Dysferlin is reduced in patients with limb girdle muscular dystrophy type 2B, Miyoshi myopathy, distal anterior compartment myopathy, and in certain Ethnic clusters. Methods: We evaluated clinical and genetic patient data from three different Swiss Neuromuscular Centers. 
Results: Thirteen patients from 6 non-related families were included. Age of onset was 18.8 +/- 4.3 years. In all patients, diallelic disease-causing mutations were identified in the DYSF gene. Nine patients from 3 non-related families from Central Switzerland carried the identical homozygous mutation, c.3031 + 2T>C. A possible founder effect was confirmed by haplotype analysis. Three patients from two different families carried the heterozygous mutation, c.1064_1065delAA. Two novel mutations were identified (c.2869C>T (p.Gln957Stop), c.5928G>A (p.Trp1976Stop)). 
Conclusions: Our study confirms the phenotypic heterogeneity associated with DYSF mutations. Two mutations (c.3031 + 2T>C, c.1064_1065delAA) appear common in Switzerland. Haplotype analysis performed on one case (c.3031 + 2T>C) suggested a possible founder effect.
KW  - gene mutations
KW  - miyoshi myopathy
KW  - gridle muscular-dystrophy
KW  - features
KW  - deficiency
KW  - heterogeneity
KW  - 2B
KW  - italian patients
KW  - molecular analysis
KW  - membrane repair
Y1  - 2015
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-139920
VL  - 15
IS  - 182
ER  - 
TY  - JOUR
A1  - Gaiser, Timo
A1  - Geissinger, Eva
A1  - Schattenberg, Torsten
A1  - Scharf, Hanns-Peter
A1  - Dürken, Matthias
A1  - Dinter, Dietmar
A1  - Rosenwald, Andreas
A1  - Marx, Alexander
T1  - Case report: a unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal muscle
JF  - Diagnostic Pathology
N2  - Primary involvement of skeletal muscle is a very rare event in ALK-1 positive anaplastic large cell lymphoma (ALCL). We describe a case of a 10-year old boy presenting with a three week history of pain and a palpable firm swelling at the dorsal aspect of the left thigh. Histological examination of the lesion revealed a tumoral and diffuse polymorphic infiltration of the muscle by large lymphoid cells. Tumor cells displayed eccentric, lobulated "horse shoe" or "kidney-shape" nuclei. The cells showed immunohistochemical positivity for CD30, ALK-1, CD2, CD3, CD7, CD8, and Perforin. Fluorescence in situ hybridization analysis revealed a characteristic rearrangement of the ALK-1 gene in 2p23 leading to the diagnosis of ALK-1 positive ALCL. Chemotherapy according to the ALCL-99-NHL-BFM protocol was initiated and resulted in a complete remission after two cycles. This case illustrates the unusual presentation of a pediatric ALCL in soft tissue with a good response to chemotherapy.
KW  - pediatric lymphoma
KW  - psoas muscle
KW  - classification
KW  - translocation
KW  - features
KW  - gene
KW  - ALK-1
KW  - anaplastic large cell lymphoma
KW  - CD30
Y1  - 2012
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-135381
VL  - 7
IS  - 38
ER  -